Contact Us
Physician Portal
86.2% of patients achieved complete closure with use of TTAX01 in the follow-up study, up from 50% confirmed closure during the original 16-week trial. Miami, FL – June 1, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from […]
Archive for 2020
Cryopreserved umbilical cord allograft is a novel treatment option due to its unique properties promoting a regenerative wound healing environment Miami, FL – May 18, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from a prospective, single-center, […]
Inaugural day to bring awareness to Mechanical Dry Eye, one of the most overlooked and often misdiagnosed age-related eye conditions Miami, FL – May 4, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of human birth tissue products for ocular surface disease and disorders, has announced that the first-ever […]
Live webinars focus on Ophthalmic, Wound Care, Podiatry, and Orthopedic Indications using Cryopreserved Human Birth Tissue Miami, Fla. – April 21, 2020 – TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue products and parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., announced today that they have rolled […]
RMAT designation reinforces clinical significance of investigational biologic product TTAX02 used during in-utero fetal surgical repair of spina bifida Miami, Fla. – April 16, 2020 – TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue products, announced today that the U.S. Food and Drug Administration (FDA) has granted their […]
To bring awareness to Mechanical Dry Eye (MDE), one of the most overlooked and often misdiagnosed age-related eye conditions Miami, FL – April 10, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of cryopreserved amniotic membrane products for ocular surface disease and disorders, has announced the first-ever National Mechanical […]
Bio-Tissue, Inc. (Bio-Tissue), a TissueTech, Inc. company and pioneer and market leader in the ocular surface clinical application of human birth tissue-based products, announced today the availability of a collaborative publication designed to help clinicians optimize outcomes by improving the management of cornea-involved ocular surface diseases and the preparation of the ocular surface for refractive cataract surgery, all of which present continued unmet needs.
Online platform gives physicians access to clinical resources and tools to make informed decisions and enhance patient outcomes Miami, FL –February 22, 2020 – TissueTech, Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, announced today the launch of a web-based physician portal to support clinical decision-making […]
Brandon Caraway joins organization to help build and lead a world-class sales team Miami, FL – February 22, 2020– Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the expansion of their Leadership Team with the appointment of Brandon Caraway to the position […]
Retrospective cohort study results show wound complications, re-operation and infection rates up to 70 percent lower when CLARIX is applied during open reduction and internal fixation of calcaneus fractures Miami, FL – February 20, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, […]
